Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Go back to Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates| (NYSE: MANE) | Delayed: 96.07 +1.67 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.40 | 52 Week High | $ | |||
| Open | $94.37 | 52 Week Low | $ | |||
| Day High | $98.93 | P/E | N/A | |||
| Day Low | $92.11 | EPS | $ | |||
| Volume | 260,390 | |||||

